BMRN
NASDAQ · Biotechnology
Biomarin Pharmaceutical Inc
$54.09
-0.69 (-1.26%)
Performance
1D
—
1W
—
1M
—
3M
-9.77%
6M
+0.45%
1Y
-24.38%
YTD
-9.02%
Open$54.36
Previous Close$54.78
Day High$54.37
Day Low$53.36
52W High$73.51
52W Low$50.76
Volume—
Avg Volume2.57M
Market Cap11.65B
P/E Ratio33.39
EPS$1.76
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$57.48
Below
SMA 200
$56.51
Below
RSI (14)
80.7
Overbought
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
32 analysts
Price Target
+133.8% upside
Current
$54.09
$54.09
Target
$126.44
$126.44
$89.21
$126.44 avg
$194.19
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 3.11B | 2.70B | 1.41B |
| Net Income | 336.87M | 262.73M | -2,303,166 |
| Profit Margin | 10.8% | 10.3% | -0.2% |
| EBITDA | 422.77M | 348.04M | -4,073,088 |
| Free Cash Flow | — | — | -1,983,877 |
| Rev Growth | +15.4% | +15.4% | -7.9% |
| Debt/Equity | 0.10 | 0.10 | 0.76 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $205.20 | +0.13% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $348.43 | -0.38% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.11 | +0.56% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $448.62 | -0.58% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $741.69 | +0.70% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $308.05 | +0.45% | 139.7 | 43.84B |